Sheridan Capital Partners Closes Fund III at $575 Million and Expands Healthcare Investments
Gracie Gottlieb | 11 July, 2023
Investment firm Sheridan Capital Partners has successfully closed its third buyout fund, Sheridan Capital Partners Fund III, LP, and its parallel fund at the hard cap of $575 million. The fund exceeded its target of $450 million, demonstrating strong support from global investors. Sheridan Capital Partners focuses on investments in recession-resistant, non-discretionary markets within the healthcare industry and will continue its strategy of making control investments in North American founder-owned businesses.
Jonathan Lewis, Founder & Partner of Sheridan, expressed his gratitude for the support of both existing and new investors in closing the fund in a challenging macroeconomic environment. He also emphasized the confidence the investors have shown in Sheridan Capital Partners and their commitment to pursuing opportunities within the lower middle market healthcare sector.
Fund III attracted a diverse range of international investors, including insurance companies, consultants, pensions, family offices, sovereign wealth funds, and fund-of-funds. This mix of limited partners spans across North America, Europe, and the Middle East, further highlighting the global appeal of Sheridan Capital Partners' investment strategy.
Sean Dempsey, Partner of Sheridan, emphasized the strong performance of the healthcare sector across business cycles and highlighted the firm's commitment to partnering with founder-owned businesses. By leveraging their sector expertise and operational approach, Sheridan Capital Partners aims to accelerate growth and create long-term value for investors, business owners, and management teams.
To facilitate the successful closing of Fund III, Sixpoint Partners acted as the exclusive global placement agent, while Kirkland & Ellis LLP served as fund counsel, ensuring a smooth and efficient process.
Sheridan Capital Partners, a Chicago-based private equity firm, specializes in lower middle market buyouts and growth equity in the healthcare industry in the U.S. and Canada. The firm focuses on investments in providers and provider services, healthcare IT and outsourced services, and consumer health and medical products. By providing strategic resources, Sheridan Capital Partners aims to accelerate growth, build enduring value, and achieve strong results for its portfolio companies.
For more information about Sheridan Capital Partners, please visit their website at [www.sheridancp.com](https://www.sheridancp.com).
Other Posts
- Navigating the Energy Transition: How Ascend Analytics Powers the Future
- Crescent Grove Advisors' Q4 2022 vs. Q1 2023 13F Holdings Comparison: Winners and Losers
- Unveiling Trends: Avalon Capital's Strategic Moves in the Equity Sector Through Q4 2023 and Q1 2024
- Navigating Market Shifts: How BlueSky Wealth Advisors Optimized Their Portfolio in Early 2024
- Investment Management Inc Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Grovecourt Capital Partners: Unlocking Growth Potential in Healthcare Services and Technology Sectors
- Pettyjohn, Wood & White, Inc Q4 2022 vs. Q1 2023: A Deep Dive into the Company's Portfolio Shakeup
- MissionWired and Zuri Group Partner to Enhance Tech-Enabled Nonprofit Services
- Analyzing Millrace Asset Group's Q3 2022 vs. Q4 2022 13F Holdings Comparison: Notable Changes in Equity Portfolio Holdings.
- Rho Capital Partners Inc Q3 2022 vs. Q4 2022: A Look at the Latest 13F Holdings Changes